Arjuna is renowned and reputed in central and southern Asia as being able to help heart health. So it was included as a lesser ingredient of Himalayan Harvest Super Superfood Gold.
But please, if you have any inkling of a heart condition, please consult a physician. Neither this website nor any of the products it promotes or sells are for illness. If you have a condition and have a doctor, please consult that doctor before consuming any of our products. The same applies if from reading this website you wish to go and buy any single herb from another source, for any medical condition, please consult your doctor. Medicine is their field of expertise.
The original article that the below summarizes is in Advances in Human Biology. Immediately below is a snippet from the paper which explains more of this herb:
Arjuna bark powder taken along with vasodilator and diuretics improves the symptoms of heart failure. Findings in the animal studies show that therapy with Arjuna bark reduces total cholesterol, low-density lipoprotein (LDL) and triglycerides and increases high-density lipoprotein (HDL) or good cholesterol in blood.
The original article is in Advances in Human Biology.
The next snippet is from this page in www.giaherbs.com.
WHAT IS ARJUNA USED FOR?
Research on this herb has been conducted based on traditional use for supporting cardiovascular health*. Several antioxidants including gallic acid, ellagic acid and oligomeric proanthocyanidins have been identified in Arjuna bark. One research study conducted in ninety six humans looked at several indicators of cardiovascular health as well as blood sugar metabolism and showed promise for more research to be conducted.
Regards side affects the following was found:
So far, no serious side effects have been reported with arjuna therapy. However, its long-term safety still remains to be elucidated. Though it has been found quite useful in angina pectoris, mild hypertension, and dyslipidemia, its exact role in primary/secondary coronary prevention is yet to be explored.
Below are the references that the first article refers to.
Fowkes FG, Price JF, Rumley A, Lowe GD. Hemostatic Heart Attack/Coronary Artery Disease. New York: Mount Sinai Hospital; 1977.
Dwivedi S. Terminalia arjuna Wight & Arn – A useful drug for cardiovascular disorders. J Ethnopharmacol 2007;114:114-29.
Seneviratine CK, Thabrew MI, Abeysekra AM. Antiradical and antiperoxidative effect of some plant extract used by Sri Lankan traditional medical practitioners for cardioprotection. Pyhtother Rev 2001;15:519-23.
Ram A, Lauria P, Gupta R, Kumar P, Sharma VN. Hypocholesterolaemic effects of Terminalia arjuna tree bark. J Ethnopharmacol 1997;55:165-9.
Terminalia arjuna. Altern Med Rev 1999;4:436-7.
Malik N, Dhawan V, Bahl A, Kaul D. Inhibitory effects of Terminalia arjuna on platelet activation in vitro in healthy subjects and patients with coronary artery disease. Platelets 2009;20:183-90.
Dwivedi S, Agarwal MP. Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug, in coronary artery disease. J Assoc Physicians India 1994;42:287-9.
Bharani A, Ganguli A, Mathur LK, Jamra Y, Raman PG. Efficacy of Terminalia arjuna in chronic stable angina: A double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate. Indian Heart J 2002;54:170-5.
Bharani A, Ganguly A, Bhargava KD. Salutary effect of Terminalia arjuna in patients with severe refractory heart failure. Int J Cardiol 1995;49:191-9.
Subramaniam S, Subramaniam R, Rajapandian S, Uthrapathi S, Gnanamanickam VR, Dubey GP, et al. Anti-atherogenic activity of ethanolic fraction of Terminalia arjuna bark on hypercholesterolemic rabbits. Evid Based Complement Alternat Med 2011;2011:487916.
Tiwari AK, Gode JD, Dubey GP. Effect of Terminalia arjuna on lipid profiles of rabbit fed hypercholesterolemic diet. Int J Crude Drug Res 1990;28:43-7.
Bhatia J, Bhattacharya SK, Mahajan P, Dulivedi S. Effect of Terminalia arjuna on coronary flow – An experimental study. Indian J Pharmacol 1998;30:118.
Verma SK, Bordia A, et al. Efficacy of Terminalia arjuna in chronic stable angina; a double blind placebo – Controlled, crossover study. J Res Edu Ind Med 1995;9:180-4.
Namm S, Guda Valli R, Babu BS, Lodagala DS. Possible mechanism of hypotension produced 70% alcoholic extract of Terminalia arjuna in anaesthetized dogs. BMC Complement Altern Med. 1999;7:56-61.
Dall'Ago P, Fernandes TG, Machado UF, Belló AA, Irigoyen MC. Baroreflex and chemoreflex dysfunction in streptozotocin-diabetic rats. Braz J Med Biol Res 1997;30:119-24.
Khalil S. Effect of Statin Versus Terminalia arjuna on Acute Myocardial Infarction. DNB Thesis (medicine). New Delhi, India: National Board of Examination; 2005.
Gauthaman K, Maulik M, Kumari R, Manchanda SC, Dinda AK, Maulik SK, et al. Effect of chronic treatment with bark of Terminalia arjuna: A study on the isolated ischemic-reperfused rat heart. J Ethnopharmacol 2001;75:197-201.
Karthikeyan K, Bai BR, Gauthaman K, Sathish KS, Devaraj SN. Cardioprotective effect of the alcoholic extract of Terminalia arjuna bark in an in vivo model of myocardial ischemic reperfusion injury. Life Sci 2003;73:2727-39.
Gauthaman K, Banerjee SK, Dinda AK, Ghosh CC, Maulik SK. Terminalia arjuna (Roxb.) protects rabbit heart against ischemic-reperfusion injury: Role of antioxidant enzymes and heat shock protein. J Ethnopharmacol 2005;96:403-9.
Sumitra M, Manikandan P, Kumar DA, Arutselvan N, Balakrishna K, Manohar BM, et al. Experimental myocardial necrosis in rats: Role of arjunolic acid on platelet aggregation, coagulation and antioxidant status. Mol Cell Biochem 2001;224:135-42.
Manna P, Sinha M, Sil PC. Phytomedicinal activity of Terminalia arjuna against carbon tetrachloride induced cardiac oxidative stress. Pathophysiology 2007;14:71-8.
Jain V, Poonia A, Agrawal RP, Panwar RB, Kochar DK, Mishra SN. Effect of Terminalia arjuna in patients of angina pectoris (A clinical trial). Indian Med Gaz 1992;2:56-9.